Categories Earnings, Health Care

Amicus Therapeutics (FOLD): Q3 2019 Earnings Snapshot

Earnings Update by AlphaStreet

— Amicus Therapeutics (NASDAQ: FOLD) reported Q3 2019 loss of $0.24 per share, vs. a loss of $0.32 expected.

— Revenues grew 137% to $48.8 million, vs. $47.6 million expected.

— Global revenue for Galafold was $48.8 million.

— FY19 Galafold revenue is expected to be $170 million to $180 million.

Get access to timely and accurate verbatim transcripts that are published within hours of the event.

Most Popular

Amazon (AMZN) stock remains a good bet despite poor results. Here’s why, Inc. (NASDAQ: AMZN) became an inspiration for other players in the eCommerce sector as the online retailer successfully channelized its resources to tap into the spike in demand for

WMT Earnings: All you need to know about Walmart’s Q2 2023 earnings results

Walmart Inc. (NYSE: WMT) reported second quarter 2023 earnings results today. Total revenue increased 8.4% year-over-year to $152.9 billion. Revenues grew 9.1% in constant currency. Consolidated net income attributable to

Rivian (RIVN) reaffirms production goals. Will it be a smooth ride?

The evolution of the electric vehicle industry accelerated in recent years even as innovations in battery technology and affordability brought EVs into the mainstream. Encouraged by the success of market

Add Comment
Viewing Highlight